As related by Catherine Shu in an article in TechCrunch, the Korean start-up Ybrain has raised a $3.5M Series A round to manufacture and run clinical trials with its wearable health device. This headband device is targeted at Alzheimer’s and MCI (mild cognitive impairment) patients, and is apparently a two-electrode tDCS (transcranial direct current stimulation) device. The article relates that Ybrain considers Soterix Medical as its most direct competitor; Soterix also offers higher-density tDCS, and transcutaneous spinal DCS, system

Categorised in:

This post was written by Syngli